Investigation of polyarthritis Flashcards
1
Q
History q’s
A
- how long has this been going on?
- parasite control, esp flea and tick tx
- vaccination history
- where is the animal exercised?
- any other signs i.e non-lameness related?
- recent weight loss?
- animal ever been abroad?
2
Q
CE
A
- observe from distance
- watch move -> assess gait
- TPR, mm, etc as normal CE
3
Q
Ddx for multiple limb lameness & bilateral joint effusion
A
- polyarthritis (immune mediated or septic)
- septic polyarthritides (e.g. Borrelia infection [Lyme dz])
- inflammatory bone dz e.g. metaphysical osteopathy, panosteitis, hypertrophic pulmonary osteopathy (Marie’s dz)
- myositis/myopathy
- neuropathy
- other less likely causes of lethargy & reluctance to walk might include hypoglycaemia (but this doesn’t cause joint pain)
4
Q
Diagnostic approach
A
- routine bloodwork
- serum sample (serology)
- radiographs of affected limbs
- trial therapy
- joint taps
5
Q
Trial therapy
A
- NSAIDs to reduce pyrexia and any pain that appears to originate from limbs
- see again in 1-2d time
6
Q
Other than haematology, what test can you do to determine if there’s significant inflammatory dz?
A
- C-reactive protein (CRP) assay
– rises rapidly when inflammation occurs
– falls rapidly when it resolves
– hence used to monitor therapy / course of inflammatory dz
7
Q
Types of immune mediated poly arthritis
A
- erosive (e.g. rheumatoid arthritis)
- non-erosive
8
Q
Use of serology
A
- for Borrelia
- for rheumatoid arthritis
- for systemic lupus erythematous (SLE) (multi-system dz)
9
Q
What is a marker for SLE?
A
- anti-nuclear factor
10
Q
Tx of immune mediated polyarthritis
A
- immunosuppressive doses of steroids
- analgesia: paracetamol or opiates
11
Q
How can you differentiate between septic and immune-mediated polyarthritis?
A
- synovial fluid culture
12
Q
What is type I immune-mediated polyarthritis?
A
- idiopathic
13
Q
How do some clinicians now classify polyarthritis due to difficulties in classifying some cases?
A
- primary (idiopathic) or secondary (reactive) with secondary encompassing formerly Type II, III, IV immune mediated polyarthritis classes + drug associated and those that may result from vaccination